Navigation Links
First of its kind study in Canada looks at who is taking aspirin to prevent heart attack or stroke
Date:3/19/2013

A new study out of the Faculty of Medicine & Dentistry shows a large population of healthy people are taking Aspirin to prevent cardiovascular disease, despite the fact that new literature shows it isn't as beneficial as once thought.

Olga Szafran and Mike Kolber, in the Department of Family Medicine at the University of Alberta, surveyed patients over the age of 50 at two clinics in Alberta. They found that more than 40 per cent of people who don't suffer from cardiovascular disease are popping pills daily to prevent a heart attack or stroke a practice called primary prevention.

"A lot of this comes from many years ago where they did this study on physicians and it showed that physicians who take Aspirin seem to do better than those who don't," said Kolber. "The problem is, physicians aren't a generalized group of people, physicians are healthier and they're educated. All the literature that's been coming out over the last three to five years, said Aspirin for primary prevention really doesn't change long-term mortality."

Their data also shows that 62 per cent of those who have cardiovascular disease are following the same regimen. This is called secondary prevention, and this group that really benefits from a daily Aspirin.

Their findings are published in the journal Canadian Family Physician.

"I think the hope is that this paper will sensitize physicians to their own practice and create a growing awareness of the issue," said Szafran.

"If we can get it out there and ensure physicians and patients have the discussion, perhaps we could shift the use a little bit," said Kolber. "Discuss the importance, if you have cardiovascular disease, of taking an anti-platelet like Asprin, and probably less important if you don't have an event, to be taking that."


'/>"/>

Contact: Raquel Maurier
raquel.maurier@ualberta.ca
780-492-5986
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Page: 1

Related medicine news :

1. Spanish researchers link cancer to failures in chromosome protection for the first time
2. SiliconMesa Partners with DrFirst to Add E-prescribing and Medication Adherence Functionality to SiliconMesa EHR
3. Best Abdominal Exercise To See Faster Results From Kettlebell Workouts Video Revealed By StrongFirst Master Kettlebell Instructor Geoff Neupert
4. Results released for first multicenter study of hybrid revascularization
5. First Choice Emergency Room Opens New Facility in Colorado Springs
6. First single gene mutation shown to result in type 1 diabetes
7. First evidence that obesity gene is risk factor for melanoma
8. Researchers describe first functional HIV cure in an infant
9. Zoloft Lawsuit News: Bernstein Liebhard LLP Notes New Pretrial Order in Federal Zoloft Litigation Establishing Tentative Date for First Bellwether Trial
10. Geoff Neupert, StrongFirst Master Kettlebell Instructor, Releases New Video Detailing How To Make Seemingly Unlimited Progress With Only One Kettlebell
11. Federal NuvaRing Blood-Clotting Lawsuits Report: Resource4thePeople Updates Consumers with News That First Bellwether Trial Rescheduled to July
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: